Controlled-Release Oxycodone For Postoperative Analgesia After Video-Assisted Thoracic Surgery
Information source: University of Parma
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Anesthesia Recovery Period; Pain, Postoperative
Intervention: Morphine (Drug); oxycodone (Drug); Paravertebral block (Procedure); Propofol (Drug); Remifentanil (Drug); Paracetamol (Drug); Morphine (Drug)
Phase: Phase 4
Status: Terminated
Sponsored by: University of Parma Official(s) and/or principal investigator(s): Guido Fanelli, MD, Study Chair, Affiliation: Section of Anesthesiology and Critical Care, Dept. of Anesthesiology, University of Parma, Italy Marco Berti, MD, Study Director, Affiliation: II Unit of Anesthesia, Critical Care and Pain Medicine, University Hospital of Parma, Italy Franca Bridelli, MD, Principal Investigator, Affiliation: II Unit of Anesthesia, Critical Care and Pain Medicine, University Hospital of Parma, Italy
Summary
The main hypothesis of this study is that preoperative administration of controlled-release
(CR) oxycodone may reduce acute postoperative pain and improve time to discharge from the
post-anesthesia care unit in patients undergoing video-assisted thoracoscopy for spontaneous
pneumothorax.
The study drug will be compared with intravenous morphine administered 30 minutes before the
end of anesthesia.
Clinical Details
Official title: Preoperative Controlled-Release Oxycodone or Intraoperative Morphine As Transition Opioid After Intravenous Anesthesia For Video-Assisted Thoracic Surgery: a Randomized, Double-blind, Controlled Trial.
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Morphine consumption (intravenous titration in PACU + i.v. patient-controlled pump usage)
Secondary outcome: Pain intensity as measured on a visual analog scaleTime to discharge from post-anesthesia care unit (Aldrete score >9) Nausea or vomiting Respiratory depression (SpO2 < 92% or respiratory rate <8)
Detailed description:
Although spontaneous pneumothorax may be treated conservatively by simple observation or
chest tube insertion, up to 50% of patients treated conservatively may experience recurrence
in subsequent months or years.
Video-assisted thoracic surgery (VATS) is a minimally-invasive surgical approach to treat
spontaneous pneumothorax and reduce the risk of recurrence. Compared to open thoracotomy,
VATS may facilitate a faster recovery and lead to earlier home discharge.
Totally-intravenous anesthesia (TIVA) with propofol and remifentanil is a useful anesthetic
technique for VATS, as the drugs are rapidly eliminated after the end of the procedure,
leading to fast recovery from anesthesia.
One drawback of ultra-short-acting opioid remifentanil is residual hyperalgesia after the
end of the infusion, particularly after VATS, which is associated with relatively short but
intense pain after surgery.
Intravenous morphine, administered just before the end of anesthesia, is the typical choice
for pain relief after TIVA. However, this drug may require repeated titration and may be
associated with postoperative nausea and vomiting, itchiness or drowsiness in the early
postoperative period.
Oxycodone, another opioid, is available in an oral controlled-release (CR) formulation which
grants relatively constant plasma levels of the drug after 1 h of administration.
The investigators hypothesize that administration of CR oxycodone 20 mg 1 hour before
surgery may lead to better recovery parameters in the post-anesthesia care unit, thus
granting earlier discharge to the surgical ward.
Eligibility
Minimum age: 18 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients scheduled for video-assisted thoracic surgery for clinical diagnosis of
spontaneous pneumothorax
- Must be able to swallow tablets 1 h before surgery
- American Society of Anesthesiologists (ASA) physical status class I or II
Exclusion Criteria:
- Known allergy or other contraindications to study drugs
- Acute myocardial infarction ≤6 months before enrollment
- Serum creatinine > 2 mg/dL
- Body mass index (BMI) > 30
- Diagnosis of psychiatric disorders
- Known or possible pregnancy
- Epilepsy
- Chronic opioid therapy or abuse
Locations and Contacts
University Hospital / Azienda Ospedaliero-Universitaria, Parma, PR 43100, Italy
Additional Information
Related publications: Noppen M, Baumann MH. Pathogenesis and treatment of primary spontaneous pneumothorax: an overview. Respiration. 2003 Jul-Aug;70(4):431-8. Review. Hansen EG, Duedahl TH, Rømsing J, Hilsted KL, Dahl JB. Intra-operative remifentanil might influence pain levels in the immediate post-operative period after major abdominal surgery. Acta Anaesthesiol Scand. 2005 Nov;49(10):1464-70. Sunshine A, Olson NZ, Colon A, Rivera J, Kaiko RF, Fitzmartin RD, Reder RF, Goldenheim PD. Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol. 1996 Jul;36(7):595-603. Vogt A, Stieger DS, Theurillat C, Curatolo M. Single-injection thoracic paravertebral block for postoperative pain treatment after thoracoscopic surgery. Br J Anaesth. 2005 Dec;95(6):816-21. Epub 2005 Sep 30. Kaya FN, Turker G, Basagan-Mogol E, Goren S, Bayram S, Gebitekin C. Preoperative multiple-injection thoracic paravertebral blocks reduce postoperative pain and analgesic requirements after video-assisted thoracic surgery. J Cardiothorac Vasc Anesth. 2006 Oct;20(5):639-43. Epub 2006 Aug 8.
Starting date: July 2008
Last updated: January 5, 2012
|